About This Webinar
Many osteoporosis, fracture liaison and DXA services closed during the first wave of the coronavirus pandemic forcing innovative and new ways of working to support access to treatment for patients most at risk of fragility fracture.

There are new challenges as services have resumed activity and face inevitable backlogs and experiences have been varied. With a pivot towards more virtual patient interactions tools have been developed to support the clinician in having ‘the best conversation’ with their patient to support patient care and outcomes.

Consideration must be given to how DXA services are used to their maximum patient benefit and use of fracture risk assessment tools and new pathways may support this optimisation.

The handout for this session is available by clicking the handout icon in the bottom right-hand corner of the video player.

Poll Results:

Are you aware of FLS services as a concept
Yes (92%)
No (8%)

Does your trust/CCG/ICS have an FLS service?
Yes (67%)
No (21%)
Don't know (12%)

What do we most use DXA for?
Diagnoses of Osteoporosis (46%)
Evidence treatment threshold (4%)
Enhanced Fracture risk assessment (37%)
Monitor response to therapy (7%)
Monitor changes to bone mass over time (7%)

Have you made use of virtual consultations in your practice over the last 12 months?
Yes (78%)
No (22%)

Presenter
  • 1624109330-9e81cfec30525d0f
    Jill Griffin
    Professional Development Lead & Clinical Lead – Vertebral Fractures, Royal Osteoporosis Society

    Jill Griffin DCR (R), qualified in 1993 from Bristol and specialised in bone densitometry (DXA) and MRI. As a consultant radiographer at Healthy Bones Plymouth, Jill clinically led, developed and promoted quality improvements in DXA scanning.

    Jill has been engaged with the Royal Osteoporosis Society (ROS) for over a decade as a clinical expert and Chair of the National Training Scheme for Bone Densitometry until 2020.

    Jill was appointed as Clinical Lead for Vertebral Fractures to the ROS in 2018 and Professional Development Lead in 2020 and is responsible for the clinical leadership of the ROS’ vertebral fracture programme. Jill also leads on the professional development and training programmes for health care professionals within the charity.

    Jill was co-author on the charity’s clinical guidance for effective vertebral fracture identification and reporting of DXA in adult fracture risk assessment and represents the ROS as a co-investigator on several research studies on bone health and fracture care.
Powered by BigMarker